Pfizer was one of the nine companies in September that took a stance to "stand with science" and not rush a vaccine that hasn't been properly vetted.
The Food and Drug Administration insists companies have at least two months of data on half of the people participating in the trial after their final dose before approving the Emergency Use Authorization.
Pfizer announced Friday it won't apply its vaccine for emergency authorization until after the election — despite President Donald Trump insisting it would have a cure before the elections.
However, of the four companies currently in the late-stage testing phase of their vaccines, Pfizer's aggressive timeline goals are beating Moderna Inc. (Nasdaq: MRNA), AstraZeneva Plc. (Nasdaq: AZN) and Johnson & Johnson (NYSE: JNJ).
With so many eyes on this company the past few months, the stock market has begun to take notice… and so have I.
You see, after taking a look at the charts I noticed a major coronavirus vaccine play being made with the pay-off potential of $7.2 million… in the next 38 days… on a $1.1 million outlay. |
0 Response to "2 Hot Robinhood Stocks Investors Keep Buying"
Post a Comment